Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences.
Magnetic susceptibility contrast variations in multiple sclerosis lesions.
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
Acute disseminated encephalomyelitis following inactivated influenza vaccination in the Brazilian Amazon: a case report.
InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
Long-distance effects of inflammation on differentiation of adult spinal cord neural stem/progenitor cells.
Newer therapies for multiple sclerosis.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Specificities of children with multiple sclerosis and neuromyelitis optica.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.
In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.
Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
[Treatment of multiple sclerosis: new approaches to treat case by case].
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE).
Next-Generation Sequencing Identifies MicroRNAs that Associate with Pathogenic Autoimmune Neuroinflammation in Rats.
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Pharmacology and Structure of P2Y Receptors.
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
Pages
« first
‹ previous
…
616
617
618
619
620
621
622
623
624
…
next ›
last »